Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Affimed completes follow-on

    Cancer company Affimed N.V. (NASDAQ:AFMD) raised $18 million through the sale of 10 million shares at $1.80 on Jan. 20 in a follow-on underwritten by BMO Capital Markets, Wells Fargo Securities and Trout Capital.Affimed…

    Published on 1/23/2017
  • ARTSaVIT completes venture financing

    On Jan. 5, cancer apoptosis company ARTSaVIT Ltd. (Yavne, Israel) raised $6.3 million in a series A round co-led by Arkin Bio Ventures and Pontifax. Merck Ventures, Carmel Innovation and Carmel-Haifa University Economic…

    Published on 1/23/2017
  • Can-Fite completes direct public offering

    Cancer and inflammatory disease company Can-Fite BioPharma Ltd. (Tel Aviv:CFBI; NYSE-M:CANF) raised $5 million through the sale of 2.5 million ADSs at $2 in a registered direct offering with institutional investors on …

    Published on 1/23/2017
  • Cristal Therapeutics completes venture financing

    On Jan. 19, nanomedicine company Cristal Therapeutics (Maastricht, the Netherlands) raised 12.8 million ($13.6 million) in a venture round led by Aglaia Biomedical Ventures and Droia Oncology Ventures. BOM, NV …

    Published on 1/23/2017
  • Egalet completes private placement of senior notes

    On Jan. 18, pain and drug delivery company Egalet Corp. (NASDAQ:EGLT) raised $40 million in the second and final tranche of a senior secured notes offering to institutional investors, bringing the total raised to $80 …

    Published on 1/23/2017
  • EnteroMedics completes follow-on

    On Jan. 18, metabolic medical device company EnteroMedics Inc. (NASDAQ:ETRM) raised $16.5 million through the sale of 751,412 class A units at $5.31 and 12,531 class B units at $1,000 in a follow-on underwritten by …

    Published on 1/23/2017
  • Heron Therapeutics completes follow-on

    On Jan. 19, drug delivery company Heron Therapeutics Inc. (NASDAQ:HRTX) raised $150 million through the sale of 12.3 million shares at $12.20 in a follow-on underwritten by BofA Merrill Lynch, Cowen, Leerink Partners, …

    Published on 1/23/2017
  • InMed completes private placement

    On Jan. 18, cannabinoid-based therapeutics developer InMed Pharmaceuticals Inc. (CNSX:IN; OTCQB:IMLFF) raised C$1.5 million ($1.1 million) through the sale of 8.3 million shares at C$0.18 in a private placement.InMed …

    Published on 1/23/2017
  • Matinas BioPharma completes warrant exercise

    On Jan. 19, infectious disease and drug delivery company Matinas BioPharma Holdings Inc. (OTCQB:MTNB) said it raised $13.5 million through the exercise of 31 million warrants.Matinas BioPharma Holdings Inc. (OTCQB:MTNB…

    Published on 1/23/2017
  • Neurelis completes venture financing

    On Jan. 5, neurology and drug delivery company Neurelis Inc. (San Diego, Calif.) raised $10 million in the first tranche of a series B round led by HBM Healthcare Investments. Existing investor LYZZ Capital also …

    Published on 1/23/2017
  • Octimet Oncology completes venture financing

    On Jan. 19, cancer play Octimet Oncology N.V. (Beerse, Belgium) raised 11.3 million ($12 million) in a series A round co-led by V-Bio Ventures and Fund+. Droia Oncology Ventures and Omnes Capital also participated.…

    Published on 1/23/2017
  • PharmaFluidics completes venture financing

    On Jan. 17, chromatography supply company PharmaFluidics N.V. (Ghent, Belgium) raised 2.7 million ($2.9 million) from new investors and existing investors Qbic Arkiv Fund, PMV, Theodorus Fund, Innovation Fund and …

    Published on 1/23/2017
  • PhaseBio completes venture financing

    On Jan. 18, metabolic and cardiovascular company PhaseBio Pharmaceuticals Inc. (Malvern, Pa.) raised $14.7 million through the sale of convertible notes to existing investors New Enterprise Associates, AstraZeneca plc, …

    Published on 1/23/2017
  • Pluristem completes follow-on

    On Jan. 20, regenerative medicine company Pluristem Therapeutics Inc. (NASDAQ:PSTI; Tel Aviv:PSTI) raised $15 million through the sale of 12.2 million units at $1.23 in a follow-on underwritten by H.C. Wainwright. Each …

    Published on 1/23/2017
  • Stemline completes follow-on

    On Jan. 20, cancer company Stemline Therapeutics Inc. (NASDAQ:STML) raised $45 million through the sale of 4.5 million shares at $10 in a follow-on underwritten by Jefferies, Cowen, Ladenburg Thalmann, H.C. Wainwright, …

    Published on 1/23/2017
  • Xtant completes direct public offering

    On Jan. 18, orthopedic company Xtant Medical Holdings Inc. (NYSE-M:XTNT) raised $480,000 through the sale of 843,239 shares at $0.57 in a registered direct offering with existing investors.Xtant Medical Holdings Inc. (…

    Published on 1/23/2017
  • Zynerba completes follow-on

    On Jan. 19, synthetic cannabinoid company Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) raised $50.4 million through the sale of 2.8 million shares at $18 in a follow-on underwritten by Jefferies, Piper Jaffray, Cantor …

    Published on 1/23/2017
  • Domain Associates financial update

    Domain Associates LLC (Princeton, N.J.) raised $163.6 million towards its Domain Partners IX L.P., according to an SEC filing on Dec. 7. The firm invests in pharmaceutical, diagnostic and medical device companies.Domain…

    Published on 1/23/2017
  • New Enterprise Associates financial update

    New Enterprise Associates (Baltimore, Md.) set a $3 billion target for its New Enterprise Associates 16 fund, according to an SEC filing on Jan. 17. The firm invests in technology and healthcare.New Enterprise …

    Published on 1/23/2017
  • Qiming Venture Partners financial update

    Qiming Venture Partners (Shanghai, China) has set a $125 million target for its planned Qiming U.S. Healthcare Fund L.P., according to an SEC filing on Jan. 11. The firm invests in healthcare companies as well as IT and…

    Published on 1/23/2017
  • Lysogene proposes IPO

    On Jan. 10, gene therapy company Lysogene S.A. (Neuilly-sur-Seine, France) filed its document with the Autorit des Marchs Financiers (AMF) for a planned IPO on Euronext Paris.Lysogene S.A., Neuilly-sur-Seine, France

    Published on 1/23/2017
  • Adynxx completes venture financing

    Adynxx raised $16 million in a series B round led by new investor TPG Biotech. Existing investor Domain Associates participated.Adynxx Inc., San Francisco, Calif.

    Published on 1/16/2017
  • Akers completes follow-on

    Akers raised $2 million through the sale of 1.7 million shares at $1.20 in a follow-on underwritten by Joseph Gunnar. Investors also received five-year warrants to purchase up to 833,500 shares at $1.50.Akers …

    Published on 1/16/2017
  • AOBiome completes venture financing

    AOBiome raised $30 million in venture financing from the iCarbonX ecosystem.AOBiome LLC, Cambridge, Mass.

    Published on 1/16/2017
  • CiVi Biopharma completes venture financing

    CiVi raised $40 million in a series A round from Tavistock Group.CiVi Biopharma Inc.

    Published on 1/16/2017

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993